Clinical trial
Intravenous (IV) Lidocaine for Opioid-refractory Pain
NCT00321347 · San Diego Hospice & Palliative Care, Other · Withdrawn
Key facts
| NCT number | NCT00321347 |
|---|---|
| Title | Intravenous (IV) Lidocaine for Opioid-refractory Pain |
| Official title | A Randomized, Placebo Controlled Phase II Study of Parenteral Lidocaine's Ability To Acutely Relieve Opioid Refractory Pain |
| Lead sponsor | San Diego Hospice & Palliative Care, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neoplasms, Pain |
| Intervention type | Drug |
| Interventions | Lidocaine |
| Enrollment | 0 |
| Start date | May 1, 2006 |
| Completion | May 1, 2009 |
| First posted | May 3, 2006 |
| Last update posted | Jun 22, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: